Catherine Toner-Bartelds

In October 2023 I joined the group of Emile Voest. Here, my project focuses on investigating the influence of the microbiome on response to immune checkpoint blockade (ICB) therapy. Furthermore, I hope to explore ways in which we can modulate the microbiome to enhance ICB response.